Patents by Inventor Christoph Volkel

Christoph Volkel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid pharmaceutical agent formulation for a piperazine urea derivative
    Publication number: 20030087913
    Abstract: A solid pharmaceutical agent formulation that contains (2R)-1-((4-chloro-2-(ureido)phenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine or a salt thereof is described.
    Type: Application
    Filed: October 18, 2002
    Publication date: May 8, 2003
    Applicant: Schering AG
    Inventors: Heiko Kranz, Christoph Volkel, Ralph Lipp, Johannes Tack, Herbert Wiesinger
  • Transdermal therapeutic system
    Publication number: 20030044453
    Abstract: The invention relates to a transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion in combination with at least one destructuring agent and/or at least one structuring agent in a common matrix.
    Type: Application
    Filed: August 2, 2002
    Publication date: March 6, 2003
    Inventors: Michael Dittgen, Sabine Fricke, Christoph Volkel, Kathrin Ahrens, Hagen Gerecke, Kai Kopke
  • Injectable implant
    Patent number: 6303137
    Abstract: This invention relates to an in-situ implant that can be produced by placing a sterile, injectable, and water-insoluble complex from a biodegradable polymer and a biocompatible polyether with functional end-groups in the organism, and coagulating them under the influence of the body fluid. This coagulate may optionally contain at least one bioactive substance selected from the group of hormones, immunomodulators, immunosuppressants, antibiotics, cytostatics, diuretics, gastro-intestinal agents, analgesics, local anaesthetics and/or neuropharmacological agents.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: October 16, 2001
    Assignee: Jenapharm GmbH & Co. KG
    Inventors: Michael Dittgen, Sabine Fricke, Hagen Gerecke, Ines-Patricia Möller, Christoph Völkel
  • Transdermal compositions with enhanced skin penetration properties
    Publication number: 20010018073
    Abstract: The invention relates to a transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion in combination with at least one destructuring agent and/or at least one structuring agent in a common matrix.
    Type: Application
    Filed: March 5, 2001
    Publication date: August 30, 2001
    Applicant: JENAPHARM GMBH & CO., KG
    Inventors: Michael Dittgen, Sabine Fricke, Christoph Volkel, Kathrin Ahrens, Hagen Gerecke, Kai Kopke
  • Transdermal compositions with enhanced skin penetration properties
    Patent number: 6238284
    Abstract: The invention relates to a transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion in combination with at least one destructuring agent and/or at least one structuring agent in a common matrix.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: May 29, 2001
    Assignees: Jenapharm GmbH & Co. KG, LTS Lohmann Therapie-Systeme AG
    Inventors: Michael Dittgen, Sabine Fricke, Christoph Völkel, Kathrin Ahrens, Hagen Gerecke, Kai Köpke